Request Demo
Last update 08 Nov 2025
Calcium Carbonate/Risedronate Sodium
Last update 08 Nov 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Actonel With Calcium (Copackaged) |
Target |
Action inhibitors, modulators |
Mechanism FDPS inhibitors(Farnesyl diphosphate synthase inhibitors), Bone development modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (12 Aug 2005), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaCH2CaO3 |
InChIKeyFYHXNYLLNIKZMR-UHFFFAOYSA-N |
CAS Registry471-34-1 |
View All Structures (2)
Related
2
Clinical Trials associated with Calcium Carbonate/Risedronate SodiumNCT00452439
A Randomized, Double Blinded Study of Actonel for the Prevention of Bone Loss in Patients Receiving High Dose Corticosteroids for the Treatment of Acute Lymphocytic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
NCT00092040
A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Risedronate on Bone Mineral Density in Postmenopausal Women With Osteoporosis; A 12 Month Extension to: A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Risedronate on Bone Mineral Density in Postmenopausal Women With Osteoporosis
100 Clinical Results associated with Calcium Carbonate/Risedronate Sodium
Login to view more data
100 Translational Medicine associated with Calcium Carbonate/Risedronate Sodium
Login to view more data
100 Patents (Medical) associated with Calcium Carbonate/Risedronate Sodium
Login to view more data
100 Deals associated with Calcium Carbonate/Risedronate Sodium
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Osteoporosis, Postmenopausal | United States | 12 Aug 2005 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | 72 | Vitamin D+Actonel (Risedronate) (Actonel) | kdquezdzbz(dobxihcjxd) = ydnoqunyow jxpvzmhauk (wjissokkge, 0.05) View more | - | 28 Dec 2020 | ||
Vitamin D (Placebo) | kdquezdzbz(dobxihcjxd) = gqvzgftflb jxpvzmhauk (wjissokkge, 0.04) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free